Related Experiment Video
Updated: Apr 4, 2026
08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
5.3K
Pediatric Allergic Contact Dermatitis: Lessons for Better Care
Alina Goldenberg1, Nanette Silverberg2, Jonathan I Silverberg3
1Medical Student, University of California San Diego, La Jolla, Calif.
The Journal of Allergy and Clinical Immunology. in Practice
|September 13, 2015
Summary
Allergic contact dermatitis (ACD) is an immune-mediated condition often missed in children. Patch testing is key for diagnosing pediatric ACD, guiding management, and identifying research gaps.
Area of Science:
- Pediatric Dermatology
- Immunology
- Allergy
Background:
- Allergic contact dermatitis (ACD) is an underrecognized immune condition in children.
- It arises from sensitization and elicitation by haptens.
- Clinical history and physical exams can suggest ACD.
Purpose of the Study:
- To provide an overview of pediatric ACD.
- To analyze current literature on pediatric ACD.
- To offer management recommendations and identify research gaps.
Main Methods:
- Literature review of pediatric ACD.
- Analysis of diagnostic criteria.
- Evaluation of management strategies.
Main Results:
- Patch testing is the gold standard for ACD diagnosis in children.
- Early recognition and diagnosis are crucial for effective management.
- Knowledge gaps exist in understanding and managing pediatric ACD.
Conclusions:
- Pediatric ACD requires greater recognition and timely diagnosis.
- Patch testing is essential for confirming ACD in children.
- Further research is needed to address knowledge gaps in pediatric ACD.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
145
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
145
01:30Allergic Reactions: Anaphylaxis
181
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
181
02:06Allergic Reactions
33.7K
Overview
33.7K
01:27Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
01:29Drug Dosing: Infants and Children
782
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
782
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
377
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377